MyFinsight
Home
Blog
About
Contact
Download
Download image
In-process research and
development, net of...
$72,826,562
Inventory
$22,639,342
Cash and cash
equivalents
$7,295,451
Accounts receivable, net
of allowances
$4,049,111
Prepaid expenses
$3,162,940
Total other assets
$72,826,562
Total current assets
$37,146,844
Total assets
$109,973,406
Total liabilities and
stockholders equity
$109,973,406
Total stockholders
equity
$58,413,701
Total liabilities
$51,559,705
Accumulated deficit
-$69,574,025
Additional paid-in capital
$127,979,246
Total current
liabilities
$44,710,394
Note payable to
related party-Related...
$3,800,111
Deferred tax liability
$3,049,200
Common stock - 0.0001
par value...
$8,480
License payable
$18,250,000
Due to related
party-Related Party
$11,494,578
Accounts payable
$10,446,900
Accrued expenses
$4,518,916
Back
Back
Balance Sheet
source: myfinsight.com
CITIUS ONCOLOGY, INC. (CTOR)
CITIUS ONCOLOGY, INC. (CTOR)